SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVR: BULLS AND BEARS!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paper man who wrote (5993)5/14/1998 11:16:00 PM
From: OLD JAKE JUSTUS  Read Replies (2) of 8902
 
The revenue potential for Reticulose in the Mercosur Countries alone is very high. Yes, Sir you are correct in your hopes and dreams. I personally think ADVR should be $2 or $3 right now. I hope it moves up in price and volume. But, I have no crystal ball and like almost all other people, I do not know the price drifts of ADVR, tomorrow or a year from now.

I do think from technical analysis that ADVR is headed higher. But, that means nothing. Because, anyone can flip a coin and come out about the same.

Let us hope for the best. God Bless and take care!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News